What are the mechanisms of action and clinical trial results for these new therapies?

Jul 20, 2005 ... Non–HDL-C and the ratio of total cholesterol to HDL-C were as good as or better than apolipoprotein fractions in the prediction of future cardiovascular events. May 27, 2019 ... This study examines trends in non–HDL-C and LDL-C levels in a free living population of ASCVD subjects between 1999 and 2016. This blood test checks the levels of cholesterol in your body. A lipid panel will show the levels of your total cholesterol, your LDL (bad) cholesterol, and ... Jan 5, 2017 ... Previous epidemiologic studies have shown that non-HDL-C is more strongly associated with coronary heart disease risk than LDL-C [3–5]. In ... Sep 30, 2023 ... Non-HDL-C is an important residual risk factor for CVD particularly the high-risk and statin-treated patients with LDL-C within the target range ... A pooled evaluation of 1,127 population-based studies comprising 102.6 million adults globally suggests an optimal non-HDL-C cholesterol of 70-85 mg/dL (1.8-2.2 ... Conclusion: Patients with normal coronary angiogram were found to have normal non-HDL-C levels and those with coronary lesions had elevated non-HDL-C. The mean ... Non-HDL cholesterol, also known as non-HDL-C, is a way of measuring how much of the bad kinds of cholesterol you have in your blood. Mar 20, 2008 ... Those with high levels of non-HDL cholesterol were 1.6 times more likely to have an LAA stroke. “In the past, many of these other lipid ... Mar 27, 2019 ... Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness ...